Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10942930rdf:typepubmed:Citationlld:pubmed
pubmed-article:10942930lifeskim:mentionsumls-concept:C0009450lld:lifeskim
pubmed-article:10942930lifeskim:mentionsumls-concept:C0012634lld:lifeskim
pubmed-article:10942930lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:10942930lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:10942930lifeskim:mentionsumls-concept:C0080103lld:lifeskim
pubmed-article:10942930lifeskim:mentionsumls-concept:C0009566lld:lifeskim
pubmed-article:10942930lifeskim:mentionsumls-concept:C1550587lld:lifeskim
pubmed-article:10942930lifeskim:mentionsumls-concept:C0439662lld:lifeskim
pubmed-article:10942930lifeskim:mentionsumls-concept:C1831743lld:lifeskim
pubmed-article:10942930pubmed:issue8lld:pubmed
pubmed-article:10942930pubmed:dateCreated2000-12-5lld:pubmed
pubmed-article:10942930pubmed:abstractTextAutologous peripheral stem cell transplantation (APSCT) is increasingly used for various hematologic malignancies and solid tumors. The objective of this study was to analyze the immune reconstitution after APSCT and see if there was any correlation with diagnosis, age, type of high-dose therapy, CD34(+) selection of the autograft and double vs single APSCT.lld:pubmed
pubmed-article:10942930pubmed:languageenglld:pubmed
pubmed-article:10942930pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10942930pubmed:citationSubsetIMlld:pubmed
pubmed-article:10942930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10942930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10942930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10942930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10942930pubmed:statusMEDLINElld:pubmed
pubmed-article:10942930pubmed:monthAuglld:pubmed
pubmed-article:10942930pubmed:issn0390-6078lld:pubmed
pubmed-article:10942930pubmed:authorpubmed-author:HanssonMMlld:pubmed
pubmed-article:10942930pubmed:authorpubmed-author:BjörkholmMMlld:pubmed
pubmed-article:10942930pubmed:authorpubmed-author:SvenssonAAlld:pubmed
pubmed-article:10942930pubmed:authorpubmed-author:GruberAAlld:pubmed
pubmed-article:10942930pubmed:authorpubmed-author:Steingrimsdot...lld:pubmed
pubmed-article:10942930pubmed:issnTypePrintlld:pubmed
pubmed-article:10942930pubmed:volume85lld:pubmed
pubmed-article:10942930pubmed:ownerNLMlld:pubmed
pubmed-article:10942930pubmed:authorsCompleteYlld:pubmed
pubmed-article:10942930pubmed:pagination832-8lld:pubmed
pubmed-article:10942930pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:meshHeadingpubmed-meshheading:10942930...lld:pubmed
pubmed-article:10942930pubmed:year2000lld:pubmed
pubmed-article:10942930pubmed:articleTitleImmune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.lld:pubmed
pubmed-article:10942930pubmed:affiliationDepartment of Medicine, Division of Hematology, Karolinska Hospital, SE-171 76 Stockholm, Sweden. hlif@hotmail.comlld:pubmed
pubmed-article:10942930pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10942930pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:10942930pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10942930lld:pubmed